Asset Entities ASST Bargain purchase gain

Segments

Corporate & Other$66.7M—

Asset Management$0—

Medical Device$0—

Revenue$2.8M+1,516%

Operating income-$313.1M-7,588%

Net income-$265.9M-6,993%

EPS (diluted)-$4.53-175%

Cash & equivalents$95.1M+982%

Total debt$3.4M—

Total equity$714.8M+3,548%

Total assets$1.1B+21,931%

Operating cash flow-$31.0M-455%

CapEx--100%

Free cash flow-$31.0M-450%

Market cap$1.02B+1,127%

Enterprise value$932M—

P/S118.1×—

Operating margin-6,563%-18,545pp

Net margin-8,022.9%-20,291pp

FCF margin-3,856.7%—

Return on equity-189.4%+139pp

Debt / equity0×—

Current ratio11.4×+1.7×